164 related articles for article (PubMed ID: 35012441)
61. Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer.
de Resende MF; Vieira S; Chinen LT; Chiappelli F; da Fonseca FP; Guimarães GC; Soares FA; Neves I; Pagotty S; Pellionisz PA; Barkhordarian A; Brant X; Rocha RM
J Transl Med; 2013 Feb; 11():36. PubMed ID: 23398928
[TBL] [Abstract][Full Text] [Related]
62. Glucose-regulated protein 94 is a novel glioma biomarker and promotes the aggressiveness of glioma via Wnt/β-catenin signaling pathway.
Hu T; Xie N; Qin C; Wang J; You Y
Tumour Biol; 2015 Dec; 36(12):9357-64. PubMed ID: 26108996
[TBL] [Abstract][Full Text] [Related]
63. Loss of O⁶-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells.
Raguz S; Adams C; Masrour N; Rasul S; Papoutsoglou P; Hu Y; Cazzanelli G; Zhou Y; Patel N; Coombes C; Yagüe E
Biochem Pharmacol; 2013 Jan; 85(2):186-96. PubMed ID: 23122841
[TBL] [Abstract][Full Text] [Related]
64. MiR-30a-5p is induced by Wnt/β-catenin pathway and promotes glioma cell invasion by repressing NCAM.
Wang Z; Dai X; Chen Y; Sun C; Zhu Q; Zhao H; Liu G; Huang Q; Lan Q
Biochem Biophys Res Commun; 2015 Sep; 465(3):374-80. PubMed ID: 26255203
[TBL] [Abstract][Full Text] [Related]
65. Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression.
Schaefer-Klein JL; Murphy SJ; Johnson SH; Vasmatzis G; Kovtun IV
PLoS One; 2015; 10(11):e0142327. PubMed ID: 26560244
[TBL] [Abstract][Full Text] [Related]
66. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.
Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y
Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699
[TBL] [Abstract][Full Text] [Related]
67. β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.
Chen L; Huang K; Han L; Shi Z; Zhang K; Pu P; Jiang C; Kang C
Int J Oncol; 2011 Oct; 39(4):883-90. PubMed ID: 21720709
[TBL] [Abstract][Full Text] [Related]
68. Expression analysis of p16 and TOP2A protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.
Zuberi Z; Mremi A; Chilongola JO; Semango G; Sauli E
PLoS One; 2021; 16(10):e0259096. PubMed ID: 34705880
[TBL] [Abstract][Full Text] [Related]
69. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
70. SPOP is essential for DNA-protein cross-link repair in prostate cancer cells: SPOP-dependent removal of topoisomerase 2A from the topoisomerase 2A-DNA cleavage complex.
Watanabe R; Maekawa M; Hieda M; Taguchi T; Miura N; Kikugawa T; Saika T; Higashiyama S
Mol Biol Cell; 2020 Mar; 31(6):478-490. PubMed ID: 31967940
[TBL] [Abstract][Full Text] [Related]
71. α-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of β-catenin transactivation.
Ji H; Wang J; Fang B; Fang X; Lu Z
J Neurooncol; 2011 Jul; 103(3):445-51. PubMed ID: 20872274
[TBL] [Abstract][Full Text] [Related]
72. Kindlin-2 interacts with β-catenin and YB-1 to enhance EGFR transcription during glioma progression.
Ou Y; Zhao Z; Zhang W; Wu Q; Wu C; Liu X; Fu M; Ji N; Wang D; Qiu J; Zhang L; Yu C; Song Y; Zhan Q
Oncotarget; 2016 Nov; 7(46):74872-74885. PubMed ID: 27713156
[TBL] [Abstract][Full Text] [Related]
73. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
[TBL] [Abstract][Full Text] [Related]
74. TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced β-catenin/TCF-4 transcription.
Gu X; Yao L; Ma G; Cui L; Li Y; Liang W; Zhao B; Li K
Neuro Oncol; 2014 Jan; 16(2):217-27. PubMed ID: 24311645
[TBL] [Abstract][Full Text] [Related]
75. Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21.
Morotomi-Yano K; Yano KI
Sci Rep; 2021 Nov; 11(1):21533. PubMed ID: 34728715
[TBL] [Abstract][Full Text] [Related]
76. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
Zhang LN; Zhao L; Yan XL; Huang YH
J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
[TBL] [Abstract][Full Text] [Related]
77. TSG101 Promotes the Proliferation, Migration, and Invasion of Human Glioma Cells by Regulating the AKT/GSK3β/β-Catenin and RhoC/Cofilin Pathways.
Zhu Y; Xu Y; Chen T; Zhang Y; Ma Q; Rauniyar S; Wang L; Shi H
Mol Neurobiol; 2021 May; 58(5):2118-2132. PubMed ID: 33411238
[TBL] [Abstract][Full Text] [Related]
78. Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients.
Grenda A; Błach J; Szczyrek M; Krawczyk P; Nicoś M; Kuźnar Kamińska B; Jakimiec M; Balicka G; Chmielewska I; Batura-Gabryel H; Sawicki M; Milanowski J
Cancer Med; 2020 Jan; 9(2):605-614. PubMed ID: 31797573
[TBL] [Abstract][Full Text] [Related]
79. miR-188 Inhibits Glioma Cell Proliferation and Cell Cycle Progression Through Targeting β-Catenin.
Li N; Shi H; Zhang L; Li X; Gao L; Zhang G; Shi Y; Guo S
Oncol Res; 2018 Jun; 26(5):785-794. PubMed ID: 29268818
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
Fountzilas G; Dafni U; Bobos M; Kotoula V; Batistatou A; Xanthakis I; Papadimitriou C; Kostopoulos I; Koletsa T; Tsolaki E; Televantou D; Timotheadou E; Koutras A; Klouvas G; Samantas E; Pisanidis N; Karanikiotis C; Sfakianaki I; Pavlidis N; Gogas H; Linardou H; Kalogeras KT; Pectasides D; Dimopoulos MA
BMC Cancer; 2013 Mar; 13():163. PubMed ID: 23537287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
